中青旅(600138.SH)擬申請發行不超40億元超短融
格隆匯12月16日丨中青旅(600138.SH)公佈,為滿足公司經營發展需要,拓展融資渠道,優化債務結構,合理降低財務成本,豐富流動性管理手段,根據相關規定,結合公司實際發展需要,公司擬向中國銀行間市場交易商協會申請註冊發行總額不超過40億元的非金融企業超短期融資券額度,在額度有效期內擇機分期公開發行,單筆發行金額不超過5億元。本次超短融的期限不超過270天,採取固定利率形式,本息支付方式為到期一次還本付息。扣除發行費用後,本次超短融募集資金擬用於為本公司補充流動資金、本級及下屬控股子公司的短期借款置換。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.